7th Annual Traumatic Brain Injury Conference - Academic/Non-Profit Registration (Arlington, United States - May 24-25, 2017) - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "7th Annual Traumatic Brain Injury Conference - Academic/Non-Profit" conference to their offering.

This event provides a special opportunity for a variety of stakeholders to present original research and analysis aimed at providing a full picture of the progress being made towards better diagnosis, treatment and long-term care for TBI survivors. At this annual event, physicians, nurses, neurosurgeons, scientists, and drug/diagnostic developers from all over the world network and learn from one another.

Focus areas include:

- Current Clinical Management of TBI

- Advances and Opportunities for TBI Biomarkers

- Recovery, Regeneration and Plasticity

- TBI Therapeutic Preclinical/Clinical Candidates

- Outcomes Research

- Large-scale Observational Studies of TBI

- Neuroimaging Research and Practice

- Emerging Tools for Diagnosis/Assessment of TBIs

- Preclinical/Clinical Development Models/Design

Agenda:

MAY 24, 2017

7:45 am Registration/Continental Breakfast

8:25 am Development and Characterization of Preclinical Models of Repetitive mild TBI as a Platform for Therapeutic Target Identification and Biomarker Discovery

8:50 Presentation

9:15 am NOXious Neuroinflammation: A New Therapeutic Target for Chronic Traumatic Brain Injury

9:40 am Refreshment Break/Scientific Poster Session Viewing

10:10 am Developing a Cognition Endpoint for TBI Clinical Trials

10:35 am Exosomes: Nano-restorative Therapy for the Treatment of Neurological Diseases and Injury

11:00 am VAS203 for Moderate and Severe TBI: From Clinical Phase II to Phase III

11:25 am Phenoxybenzamine as a Neuroprotective Candidate for TBI

11:50 am Clinical Development of Human Mesenchymal Stem Cells (MSCs) for Chronic Neurological Injury - the SanBio Experience

12:15 pm Luncheon

1:15 PANEL SESSION: Milestones and Existing Challenges in Preclinical and Clinical Development of TBI Therapeutics

1:45 pm The Late Effects of TBI Study (LETBI): Overview and Preliminary Findings

2:10 pm The Long-Term Effects of Penetrating and Closed Traumatic Brain Injuries

2:35 pm Comprehensive Longitudinal Analysis of the Causal Pathways for Post Concussion Symptom Reporting in OEF/OIF/OND Veterans

3:00 pm Refreshment Break/Scientific Poster Session Viewing

3:25 pm PANEL SESSION: The Long-Term Effects of Traumatic Brain Injury

3:55 pm The Canadian Traumatic Brain Injury Research Consortium (CTRC): A Collaborative Research Model

4:25 pm Rehabilitation after Concussion: a Pediatric Experience

4:50 pm Neurobiopsychosocial Model of TBI: Lessons Learned from Sports Concussion Research

5:15 pm Evening Cocktail Reception

MAY 25, 2017

7:30 am Continental Breakfast

8:00 am New Frontiers in CNS Biomarkers

8:25 am A Tale of Two Biomarkers - Changing the Paradigm for Concussion Management in the Emergency Department in Children and Adults

8:50 am Circulating Brain Damage Markers for the Diagnosis of Traumatic Brain Injury: the Questions You Never Dared to Ask

9:15 am Blood-Based Biomarkers in the Emergency Room: Utility, Diagnostic Specificity and Costs

9:40 am Refreshment Break/Scientific Poster Session Viewing

10:00 am PANEL SESSION: Trends in Biomarker Development for Traumatic Brain Injury

10:30 am Longitudinal Electrophysiological Signatures of Mild Blast Brain Injury in a Novel Mouse Model

10:55 am Rapid Detection of TBI Biomarkers Using Tbit Nanowire Technology to Reduce Unnecessary Head CT

11:20 am Traumatic Brain Injury Research: Historical and Current Perspectives

11:45 am Presentation Title

12:10 pm Luncheon

1:00 pm Presentation Title

1:25 pm Rewiring of the Hippocampus After Exposure to Concussive Blast Injury

1:50 pm Understanding the Complexities of Traumatic Brain Injury: Big Data Approach to Tackle a Big Disease

2:15 PANEL SESSION: Title to be Announced

2:50 End of Conference

For more information about this conference visit http://www.researchandmarkets.com/research/qlw2fq/7th_annual

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs